NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.
Helsinki, Finland, 2 July 2025: Reference is made to the stock exchange announcement on 26 June 2025, where Nordhealth AS (the "Company") launched an offer to purchase up to 300,000 of its own shares through a reverse book building process (the "Offering").
The application period expired at 16:30 hours (CEST) on 2 July 2025. Following the end of the application period, the Company has resolved to buy 300,000 shares at a price of NOK 36 per share, which equals approximately NOK 11 million in total.
All offers to sell shares with limits at or below NOK 36 have been allocated in full. Allocation notifications will be sent to shareholders having tendered shares in the Offering on or about 3 July 2025. The trade date is expected to be on or about 3 July 2025 and the settlement date is expected to be on or about 7 July 2025.
The settlement will be conducted on a normal delivery-versus-payment basis (DVP). Following settlement of the Offering, the Company will own 1,377,793 shares in the Company. The Company currently has 80.191.746 issued shares, where 1,077,793 are held in treasury and 79,113,953 are outstanding.
For further information, please contact:
DNB Carnegie, demand@dnb.no, +47 24 16 90 20
Charles MacBain, CEO, charles.macbain@nordhealth.com, +44 75 3903 2200
Alexander Cram, CFO, alexander.cram@nordhealth.com, +32 470 69 30 20
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 60,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with 400 employees working either remotely or from offices (collaboration hubs). Visit the Company's website at nordhealth.com (http://www.nordhealth.com).
IMPORTANT NOTICE
The Offering and the distribution of this announcement and other information in connection with the Offering may be restricted by law in certain jurisdictions (including, but not limited to, the United States, Canada, Australia and Japan). Neither the Company nor the bookrunner in the Offering assume any responsibility in the event there is a violation by any person of such restrictions. This includes shareholders who have changed their domicile to such jurisdictions but which may access their VPS accounts. Persons into whose possession this announcement or relevant information should come are required to inform themselves about and to observe any such restrictions. The Offering is not being made directly or indirectly in, or by use of the mails of, or by any means or instrumentality of interstate or foreign commerce of, or any facilities of a national securities exchange of, the United States of America, its territories and possessions, any State of the United States and the District of Columbia (the "United States") or any other jurisdiction in which this would be unlawful, require registration or other measures. This includes, but is not limited to, facsimile transmission, internet delivery, e-mail and telephones. Copies of this release and any related documents are not being, and must not be, mailed, e-mailed or otherwise distributed or sent in or into the United States or any such jurisdiction and so doing may invalidate any purported acceptance.